Literature DB >> 27984730

Naturally Occurring Off-Switches for CRISPR-Cas9.

April Pawluk1, Nadia Amrani2, Yan Zhang2, Bianca Garcia3, Yurima Hidalgo-Reyes3, Jooyoung Lee2, Alireza Edraki2, Megha Shah1, Erik J Sontheimer4, Karen L Maxwell5, Alan R Davidson6.   

Abstract

CRISPR-Cas9 technology would be enhanced by the ability to inhibit Cas9 function spatially, temporally, or conditionally. Previously, we discovered small proteins encoded by bacteriophages that inhibit the CRISPR-Cas systems of their host bacteria. These "anti-CRISPRs" were specific to type I CRISPR-Cas systems that do not employ the Cas9 protein. We posited that nature would also yield Cas9 inhibitors in response to the evolutionary arms race between bacteriophages and their hosts. Here, we report the discovery of three distinct families of anti-CRISPRs that specifically inhibit the CRISPR-Cas9 system of Neisseria meningitidis. We show that these proteins bind directly to N. meningitidis Cas9 (NmeCas9) and can be used as potent inhibitors of genome editing by this system in human cells. These anti-CRISPR proteins now enable "off-switches" for CRISPR-Cas9 activity and provide a genetically encodable means to inhibit CRISPR-Cas9 genome editing in eukaryotes. VIDEO ABSTRACT.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas; Cas9; Neisseria meningitidis; anti-CRISPR; genome editing; phage

Mesh:

Substances:

Year:  2016        PMID: 27984730      PMCID: PMC5757841          DOI: 10.1016/j.cell.2016.11.017

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  66 in total

1.  T7 vectors with modified T7lac promoter for expression of proteins in Escherichia coli.

Authors:  J Peränen; M Rikkonen; M Hyvönen; L Kääriäinen
Journal:  Anal Biochem       Date:  1996-05-01       Impact factor: 3.365

2.  FastTree 2--approximately maximum-likelihood trees for large alignments.

Authors:  Morgan N Price; Paramvir S Dehal; Adam P Arkin
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

3.  Rational design of a split-Cas9 enzyme complex.

Authors:  Addison V Wright; Samuel H Sternberg; David W Taylor; Brett T Staahl; Jorge A Bardales; Jack E Kornfeld; Jennifer A Doudna
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

4.  Structure and Engineering of Francisella novicida Cas9.

Authors:  Hisato Hirano; Jonathan S Gootenberg; Takuro Horii; Omar O Abudayyeh; Mika Kimura; Patrick D Hsu; Takanori Nakane; Ryuichiro Ishitani; Izuho Hatada; Feng Zhang; Hiroshi Nishimasu; Osamu Nureki
Journal:  Cell       Date:  2016-02-11       Impact factor: 41.582

Review 5.  An updated evolutionary classification of CRISPR-Cas systems.

Authors:  Kira S Makarova; Yuri I Wolf; Omer S Alkhnbashi; Fabrizio Costa; Shiraz A Shah; Sita J Saunders; Rodolphe Barrangou; Stan J J Brouns; Emmanuelle Charpentier; Daniel H Haft; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; Rebecca M Terns; Michael P Terns; Malcolm F White; Alexander F Yakunin; Roger A Garrett; John van der Oost; Rolf Backofen; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2015-09-28       Impact factor: 60.633

6.  A mechanism for the suppression of homologous recombination in G1 cells.

Authors:  Alexandre Orthwein; Sylvie M Noordermeer; Marcus D Wilson; Sébastien Landry; Radoslav I Enchev; Alana Sherker; Meagan Munro; Jordan Pinder; Jayme Salsman; Graham Dellaire; Bing Xia; Matthias Peter; Daniel Durocher
Journal:  Nature       Date:  2015-12-09       Impact factor: 49.962

7.  CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.

Authors:  Elitza Deltcheva; Krzysztof Chylinski; Cynthia M Sharma; Karine Gonzales; Yanjie Chao; Zaid A Pirzada; Maria R Eckert; Jörg Vogel; Emmanuelle Charpentier
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

8.  Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

Authors:  David Bikard; Chad W Euler; Wenyan Jiang; Philip M Nussenzweig; Gregory W Goldberg; Xavier Duportet; Vincent A Fischetti; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2014-10-05       Impact factor: 54.908

9.  RNA-guided editing of bacterial genomes using CRISPR-Cas systems.

Authors:  Wenyan Jiang; David Bikard; David Cox; Feng Zhang; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

10.  A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.

Authors:  Andrew Hammond; Roberto Galizi; Kyros Kyrou; Alekos Simoni; Carla Siniscalchi; Dimitris Katsanos; Matthew Gribble; Dean Baker; Eric Marois; Steven Russell; Austin Burt; Nikolai Windbichler; Andrea Crisanti; Tony Nolan
Journal:  Nat Biotechnol       Date:  2015-12-07       Impact factor: 54.908

View more
  141 in total

1.  Biochemical characterization of RNA-guided ribonuclease activities for CRISPR-Cas9 systems.

Authors:  Max J Gramelspacher; Zhonggang Hou; Yan Zhang
Journal:  Methods       Date:  2019-06-20       Impact factor: 3.608

2.  Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell-Free Transcription-Translation System.

Authors:  Ryan Marshall; Colin S Maxwell; Scott P Collins; Thomas Jacobsen; Michelle L Luo; Matthew B Begemann; Benjamin N Gray; Emma January; Anna Singer; Yonghua He; Chase L Beisel; Vincent Noireaux
Journal:  Mol Cell       Date:  2018-01-04       Impact factor: 17.970

Review 3.  Allosteric regulation of CRISPR-Cas9 for DNA-targeting and cleavage.

Authors:  Zhicheng Zuo; Jin Liu
Journal:  Curr Opin Struct Biol       Date:  2020-02-18       Impact factor: 6.809

4.  Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4.

Authors:  Ruchao Peng; Zhiteng Li; Ying Xu; Shaoshuai He; Qi Peng; Lian-Ao Wu; Ying Wu; Jianxun Qi; Peiyi Wang; Yi Shi; George F Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-29       Impact factor: 11.205

5.  Genetic engineering: A genome-editing off switch.

Authors:  Ross Cloney
Journal:  Nat Rev Genet       Date:  2016-12-28       Impact factor: 53.242

Review 6.  Mechanisms and consequences of diversity-generating immune strategies.

Authors:  Edze R Westra; David Sünderhauf; Mariann Landsberger; Angus Buckling
Journal:  Nat Rev Immunol       Date:  2017-08-07       Impact factor: 53.106

7.  Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity.

Authors:  Adair L Borges; Jenny Y Zhang; MaryClare F Rollins; Beatriz A Osuna; Blake Wiedenheft; Joseph Bondy-Denomy
Journal:  Cell       Date:  2018-07-19       Impact factor: 41.582

Review 8.  Precision Control of CRISPR-Cas9 Using Small Molecules and Light.

Authors:  Soumyashree A Gangopadhyay; Kurt J Cox; Debasish Manna; Donghyun Lim; Basudeb Maji; Qingxuan Zhou; Amit Choudhary
Journal:  Biochemistry       Date:  2019-01-22       Impact factor: 3.162

9.  A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9.

Authors:  Basudeb Maji; Soumyashree A Gangopadhyay; Miseon Lee; Mengchao Shi; Peng Wu; Robert Heler; Beverly Mok; Donghyun Lim; Sachini U Siriwardena; Bishwajit Paul; Vlado Dančík; Amedeo Vetere; Michael F Mesleh; Luciano A Marraffini; David R Liu; Paul A Clemons; Bridget K Wagner; Amit Choudhary
Journal:  Cell       Date:  2019-05-02       Impact factor: 41.582

10.  A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity.

Authors:  Alexander J Meeske; Ning Jia; Alice K Cassel; Albina Kozlova; Jingqiu Liao; Martin Wiedmann; Dinshaw J Patel; Luciano A Marraffini
Journal:  Science       Date:  2020-05-28       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.